Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept
Accrual of metastatic pulmonary carcinoid patients for therapy is usually relied on clinical and histologic characterization, with no role for the proliferation activity as defined by Ki-67 labelling index (LI). A total of 14 carcinoid patients with tumour primaries (TP) and 19 corresponding tumour...
Saved in:
Main Authors: | Giuseppe Pelosi (Author), Federica Massa (Author), Gaia Gatti (Author), Luisella Righi (Author), Marco Volante (Author), Nadia Birocco (Author), Patrick Maisonneuve (Author), Angelica Sonzogni (Author), Sergio Harari (Author), Adriana Albini (Author), Mauro Papotti (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
by: Gasperetti F, et al.
Published: (2011) -
P63 and Ki-67 expression in radicular cyst
by: Mohammed Amjed Alsaegh, et al.
Published: (2023) -
KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
by: G.S. Starodub, et al.
Published: (2016) -
Interobserver Variability of Ki-67 Measurement in Breast Cancer
by: Yul Ri Chung, et al.
Published: (2016) -
Assessment of Ki67 in Breast Cancer: A Comparison Between the Eye-10 Method, Stepwise Counting Strategy, and International System of Ki67 Evaluation
by: Maryam Kadivar, et al.
Published: (2020)